Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C15H14O7 |
| Molecular Weight | 306.2675 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@H]1C(O)C2=C(O[C@@H]1C3=CC(O)=C(O)C=C3)C=C(O)C=C2O
InChI
InChIKey=SBZWTSHAFILOTE-NOYMGPGASA-N
InChI=1S/C15H14O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,13-21H/t13?,14-,15+/m0/s1
| Molecular Formula | C15H14O7 |
| Molecular Weight | 306.2675 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Leucocianidol is a vasoprotector. It increases the resistance of vessels and decreases their permeability. Leucocianidol increases the tonicity of the veins. Leucocianidol is used in the management of capillary fragility, hemorrhoids, venolymphatic insufficiency. In combination with lidocaine and hydrocortisone, it is used in the symptomatic treatment of hemorrhoidal crisis. Leucocianidol inhibits 12-lipoxygenase.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0004052 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2116628 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Traditional herbal medicine in far-west Nepal: a pharmacological appraisal. | 2010-12-13 |
|
| A potential of some medicinal plants as an antiulcer agents. | 2010-07 |
|
| Phytochemical investigation and antimicrobial activity of Psidium guajava L. leaves. | 2010-07 |
|
| Ectopic expression of apple F3'H genes contributes to anthocyanin accumulation in the Arabidopsis tt7 mutant grown under nitrogen stress. | 2010-06 |
|
| Improving NADPH availability for natural product biosynthesis in Escherichia coli by metabolic engineering. | 2010-03 |
|
| Neighbour identity hardly affects litter-mixture effects on decomposition rates of New Zealand forest species. | 2010-02 |
|
| Brassica orthologs from BANYULS belong to a small multigene family, which is involved in procyanidin accumulation in the seed. | 2009-11 |
|
| Molecular cloning and function analysis of an anthocyanidin synthase gene from Ginkgo biloba, and its expression in abiotic stress responses. | 2008-12-31 |
|
| Arabidopsis R2R3-MYB transcription factor AtMYB60 functions as a transcriptional repressor of anthocyanin biosynthesis in lettuce (Lactuca sativa). | 2008-06 |
|
| Biotransformation of (+)-catechin into taxifolin by a two-step oxidation: primary stage of (+)-catechin metabolism by a novel (+)-catechin-degrading bacteria, Burkholderia sp. KTC-1, isolated from tropical peat. | 2008-02-08 |
|
| Early steps in proanthocyanidin biosynthesis in the model legume Medicago truncatula. | 2007-11 |
|
| Structure and reaction mechanism of basil eugenol synthase. | 2007-10-03 |
|
| Molecular and biochemical analysis of two cDNA clones encoding dihydroflavonol-4-reductase from Medicago truncatula. | 2004-03 |
|
| The C-4 stereochemistry of leucocyanidin substrates for anthocyanidin synthase affects product selectivity. | 2003-11-03 |
|
| The Arabidopsis TDS4 gene encodes leucoanthocyanidin dioxygenase (LDOX) and is essential for proanthocyanidin synthesis and vacuole development. | 2003-09 |
|
| Expression of anthocyanins and proanthocyanidins after transformation of alfalfa with maize Lc. | 2003-07 |
|
| Reaction mechanism from leucoanthocyanidin to anthocyanidin 3-glucoside, a key reaction for coloring in anthocyanin biosynthesis. | 2001-07-13 |
|
| Medicinal and ethnoveterinary remedies of hunters in Trinidad. | 2001 |
|
| Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxidation. | 1990-08-15 |
|
| Inhibition of sheep platelet arachidonate metabolism by flavonoids from Spanish and Indian medicinal herbs. | 1990-03 |
|
| Superoxide scavenging properties of flavonoids in a non-enzymic system. | 1990-01-01 |
|
| [Leucocyanidol and circulatory pathology in contraception]. | 1976-06 |
|
| [Fungicidal activity of leucocyanidol in the presence of copper]. | 1971-07 |
|
| [Synthesis of monomeric leucocyanidol]. | 1968-11-05 |
|
| [Effect of leucocyanidol on auxin catabolism]. | 1967 |
|
| [Action of leucocyanidol on blood serum in vitro]. | 1958-06-09 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:23:04 GMT 2025
by
admin
on
Mon Mar 31 18:23:04 GMT 2025
|
| Record UNII |
RAP1D6110C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1745
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C001532
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
C81117
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
m6774
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | Merck Index | ||
|
LEUCOCYANIDIN
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
CHEMBL123809
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
480-17-1
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
38691
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
SUB08448MIG
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
28574
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | RxNorm | ||
|
445881
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
11412
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
RAP1D6110C
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
100000082819
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
15758
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
3629
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY | |||
|
DTXSID80861994
Created by
admin on Mon Mar 31 18:23:04 GMT 2025 , Edited by admin on Mon Mar 31 18:23:04 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |